Macquarie Group LTD Wave Life Sciences Ltd. Transaction History
Macquarie Group LTD
- $83.5 Billion
- Q3 2025
A detailed history of Macquarie Group LTD transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Macquarie Group LTD holds 81,955 shares of WVE stock, worth $566,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,955
Previous 266,856
69.29%
Holding current value
$566,309
Previous $1.73 Million
65.97%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding WVE
# of Institutions
215Shares Held
133MCall Options Held
1.22MPut Options Held
616K-
Ra Capital Management, L.P. Boston, MA18.2MShares$126 Million2.25% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA14.6MShares$101 Million0.18% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.39MShares$58 Million0.89% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$46.6 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.3MShares$43.5 Million0.38% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $600M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...